Fesilty, Tachosil(fibrinogen human)
Evicel, TachoSil, VeraSeal (fibrinogen, human) is an unknown pharmaceutical. Fibrinogen, human was first approved as Tachosil on 2004-06-08. It is used to treat afibrinogenemia and hemorrhage in the USA. It has been approved in Europe to treat hemostasis and surgical hemostasis.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
Therapeutic Areas
Trade Name
FDA
EMA
Fesilty
Drug Products
FDA
EMA
Reference product - 351(a)
Reference product - 351(a)
Interchangeable product - 351(k)
Interchangeable product - 351(k)
Biosimilar product - 351(k)
Biosimilar product - 351(k)
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
HCPCS
No data
Clinical
Clinical Trials
422 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Hemorrhage | D006470 | MP_0001914 | R58 | 5 | 15 | 10 | 16 | 30 | 72 |
| Hemostatic disorders | D020141 | — | — | 2 | 6 | 4 | 7 | 33 | 50 |
| Blood coagulation disorders | D001778 | EFO_0009314 | D68.9 | 2 | 3 | 3 | 3 | 28 | 37 |
| Afibrinogenemia | D000347 | — | D68.2 | 2 | 7 | 9 | 4 | 13 | 31 |
| Wounds and injuries | D014947 | — | T14.8 | 4 | 7 | 2 | 3 | 13 | 25 |
| Thrombosis | D013927 | — | — | 1 | 3 | 1 | 2 | 14 | 20 |
| Surgical blood loss | D016063 | — | — | — | 2 | 4 | 1 | 7 | 14 |
| Postpartum hemorrhage | D006473 | — | O72 | 1 | 2 | 1 | 2 | 5 | 9 |
| Hemostasis | D006487 | — | — | 1 | 2 | 1 | 2 | 2 | 7 |
| Liver diseases | D008107 | EFO_0001421 | K70-K77 | — | — | 1 | 1 | 4 | 6 |
Show 38 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Inflammation | D007249 | MP_0001845 | — | — | — | 1 | — | 9 | 10 |
| Heart diseases | D006331 | EFO_0003777 | I51.9 | — | 2 | 1 | — | 6 | 9 |
| Stroke | D020521 | EFO_0000712 | I63.9 | — | 2 | 5 | — | 1 | 8 |
| Coronary artery disease | D003324 | — | I25.1 | — | 2 | 1 | — | 4 | 7 |
| Postoperative hemorrhage | D019106 | — | — | — | 3 | 1 | — | 3 | 7 |
| Endocrine system diseases | D004700 | EFO_0001379 | E34.9 | 1 | 1 | 1 | — | 3 | 6 |
| Cardiovascular diseases | D002318 | EFO_0000319 | I98 | — | 1 | 1 | — | 4 | 6 |
| Hemorrhagic shock | D012771 | — | — | 1 | 1 | 3 | — | 2 | 6 |
| Sepsis | D018805 | EFO_0001420 | A41.9 | — | — | 1 | — | 5 | 6 |
| Myocardial ischemia | D017202 | EFO_1001375 | I20-I25 | — | — | 1 | — | 4 | 5 |
Show 37 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Covid-19 | D000086382 | — | U07.1 | 1 | 1 | — | — | 15 | 17 |
| Neoplasms | D009369 | — | C80 | 4 | 1 | — | — | 1 | 6 |
| Infections | D007239 | EFO_0000544 | — | — | 1 | — | — | 4 | 5 |
| Macular degeneration | D008268 | EFO_0001365 | H35.30 | 1 | 4 | — | — | 1 | 5 |
| Thrombocytopenia | D013921 | HP_0001873 | D69.6 | — | 1 | — | — | 4 | 5 |
| Pituitary dwarfism | D004393 | EFO_1001109 | E23.0 | 2 | 1 | — | — | 2 | 5 |
| Retinal diseases | D012164 | — | H35.9 | 1 | 5 | — | — | — | 5 |
| Rare diseases | D035583 | — | — | — | 1 | — | — | 3 | 4 |
| Multiple trauma | D009104 | — | T07 | 1 | 1 | — | — | 3 | 4 |
| Retinal degeneration | D012162 | — | — | 1 | 4 | — | — | — | 4 |
Show 44 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Neutropenia | D009503 | — | D70 | 3 | — | — | — | — | 3 |
| Chemotherapy-induced febrile neutropenia | D064146 | — | — | 3 | — | — | — | — | 3 |
| Glioma | D005910 | EFO_0000520 | — | 1 | — | — | — | 1 | 2 |
| Tendinopathy | D052256 | EFO_1001434 | M77.9 | 2 | — | — | — | — | 2 |
| Alzheimer disease | D000544 | EFO_0000249 | F03 | 1 | — | — | — | 1 | 2 |
| Insulin resistance | D007333 | EFO_0002614 | E88.819 | 1 | — | — | — | 1 | 2 |
| Gastrointestinal hemorrhage | D006471 | — | K92.2 | 1 | — | — | — | — | 1 |
| Brain stem neoplasms | D020295 | EFO_1001767 | — | 1 | — | — | — | — | 1 |
| Pinealoma | D010871 | — | — | 1 | — | — | — | — | 1 |
| Neoplasm metastasis | D009362 | EFO_0009708 | — | 1 | — | — | — | — | 1 |
Show 1 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Fibrosis | D005355 | — | — | — | — | — | — | 7 | 7 |
| Pulmonary embolism | D011655 | EFO_0003827 | I26 | — | — | — | — | 7 | 7 |
| Liver cirrhosis | D008103 | EFO_0001422 | K74.0 | — | — | — | — | 7 | 7 |
| Coagulation protein disorders | D020147 | — | — | — | — | — | — | 5 | 5 |
| Venous thrombosis | D020246 | — | I82.40 | — | — | — | — | 4 | 4 |
| Burns | D002056 | — | T30.0 | — | — | — | — | 4 | 4 |
| Venous thromboembolism | D054556 | EFO_0004286 | I74 | — | — | — | — | 4 | 4 |
| Embolism | D004617 | — | — | — | — | — | — | 4 | 4 |
| Liver transplantation | D016031 | EFO_0010682 | — | — | — | — | — | 4 | 4 |
| Leukemia | D007938 | — | C95 | — | — | — | — | 4 | 4 |
Show 184 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | Fibrinogen human |
| INN | — |
| Description | Evicel, TachoSil, VeraSeal (fibrinogen, human) is an unknown pharmaceutical. Fibrinogen, human was first approved as Tachosil on 2004-06-08. It is used to treat afibrinogenemia and hemorrhage in the USA. It has been approved in Europe to treat hemostasis and surgical hemostasis. |
| Classification | Unknown |
| Drug class | — |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | — |
Identifiers
| PDB | — |
| CAS-ID | — |
| RxCUI | — |
| ChEMBL ID | CHEMBL2109072 |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | — |
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
1,707 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use